Background: Bacterial vaginosis (BV) has been suggested to be a risk factor of prematurity. However, the current methods for its diagnosis are mainly based on clinical score and/or Gram staining. They are fastidious, lack of precision, and difficult to reproduce. The aim of this study was to rationally evaluate the link between vaginal flora anomalies and prematurity using molecular methods.
Background: Methicillin-resistant Staphylococcus aureus (MRSA) infections are a serious global problem with considerable impact on morbidity and mortality, and health care costs. The epidemiology of MRSA in hospital and community settings in the developed world has been extensively studied. However, in lower and middle-income countries, and in Africa in particular, it remains largely understudied.
Methods & Materials:
We conducted a systematic review for published articles (up until November2013) on the molecular epidemiology and population structure of MRSA in Africa. English and French language eligible articles available in PubMed, EBSCOhost, ISI Web of knowledge and Scopus were retrieved. In addition, African Journals Online database was screened to identify eligible articles which are not indexed in the above databases.
Results: Seventy five eligible studies were identified, primarily from Tunisia, Egypt, Nigeria and South Africa. Twenty five studies from 12 countries reported complete data on MRSA clones (Multi Locus Sequence type and Staphylococcal Chromosomal Cassette mec element).
The community clones ST8-IV (USA300) and ST88-IV-PVL + were identified both in hospitals and in the community in Gabon, Senegal, Morocco, Cameroon, Madagascar, Nigeria and South Africa. The European clone ST80-IV-PVL + , also a community clone, was limited to Algeria, Tunisia and Egypt. "The early ancient clones" ST250-I and ST247-I thought to be declining world-wide, were identified in Nigeria and Tunisia. A new clone ST612-IV-PVL + has been recently reported in a South African hospital. The epidemic MRSA clone ST39-II (EMRSA-16) circulating in hospitals was identified in the community in Algeria. Besides, in a single study conducted in Senegal, animal-human transmission has been reported for the paediatric clone ST5-IV. A novel clone (ST239-IVa) that has not been reported elsewhere, appears to have resulted from SCCmec type IVa replacing SCCmec type III in the hospital clone ST239-III in Algeria.
Conclusion: In summary, identified MRSA clones in Africa include the major lineages circulating worldwide, while some clones appear to be over-represented or display specific epidemiological traits, such as zoonotic or community transmission. http://dx.doi.org/10.1016/j.ijid.2014.03.650
